Applicability of the methylated CpG sites of paired box 5 (PAX5) promoter for prediction the prognosis of gastric cancer

Paired box gene 5 (PAX5), a member of the paired box gene family, is involved in control of organ development and tissue differentiation. In previous study, PAX5 promoter methylation was found in gastric cancer (GC) cells and tissues. At present study, we found that the inconsistently methylated levels of PAX5 promoter were identified in the different GC tissues. The methylated CpG site count and the methylated statuses of four CpG sites (-236, -183, -162, and -152) were significantly associated with the survival of 460 GC patients, respectively. Ultimately, the methylated CpG -236 was the optimal prognostic predictor of patients identified by using the Cox regression with AIC value calculation. These findings indicated that the methylated CpG -236 of PAX5 promoter has the potential applicability for clinical evaluation the prognosis of GC.

[1]  Yen Ching Lim,et al.  Improved reduced representation bisulfite sequencing for epigenomic profiling of clinical samples , 2014, Biological Procedures Online.

[2]  Satoshi Yamashita,et al.  Estimation of the Fraction of Cancer Cells in a Tumor DNA Sample Using DNA Methylation , 2013, PloS one.

[3]  Bin Xie,et al.  Long-Lasting Changes in DNA Methylation Following Short-Term Hypoxic Exposure in Primary Hippocampal Neuronal Cultures , 2013, PloS one.

[4]  R. Kolhe,et al.  Immunohistochemical expression of PAX5 and TdT by Merkel cell carcinoma and pulmonary small cell carcinoma: a potential diagnostic pitfall but useful discriminatory marker. , 2013, International journal of clinical and experimental pathology.

[5]  M. Go,et al.  Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients , 2012, Oncogene.

[6]  J. Nekvindová,et al.  Methylation analysis of tumour suppressor genes in ovarian cancer using MS-MLPA. , 2012, Folia biologica.

[7]  H. Wilke,et al.  Treatment strategies in gastric cancer. , 2011, Deutsches Arzteblatt international.

[8]  Jun Yu,et al.  Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway , 2011, Hepatology.

[9]  B. Schafer.  Emerging Roles for PAX Transcription Factors in Cancer , 2010 .

[10]  S. Pileri,et al.  Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis. , 2009, Human pathology.

[11]  Yu Cheng,et al.  Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer , 2009, The Prostate.

[12]  M. Tez,et al.  Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization , 2008, Cancer.

[13]  V. A. Flørenes,et al.  Pax-5 expression in nonhematopoietic tissues. , 2006, American journal of clinical pathology.

[14]  David D. Smith,et al.  Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Wei Liu,et al.  B-Cell Specific Activation Protein Encoded by the PAX-5 Gene Is Commonly Expressed in Merkel Cell Carcinoma and Small Cell Carcinomas , 2005, The American journal of surgical pathology.

[16]  Minoru Toyota,et al.  Aberrant Promoter Methylation of the Transcription Factor Genes PAX5 α and β in Human Cancers , 2003 .

[17]  Minoru Toyota,et al.  Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers. , 2003, Cancer research.

[18]  Stephen L. Nutt,et al.  Commitment to the B-lymphoid lineage depends on the transcription factor Pax5 , 1999, Nature.

[19]  B. Schäfer.  Emerging roles for PAX transcription factors in cancer biology. , 1998, General physiology and biophysics.

[20]  P Gruss,et al.  Pax: a murine multigene family of paired box-containing genes. , 1991, Genomics.